NeuroScientific Biopharmaceuticals Ltd. announced the appointment of Dr Linda Friedland as an independent Non-executive Director effective October 18, 2023. Dr. Friedland is a physician with over 25 years of experience in clinical medicine and an international advisor to many Fortune and Forbes global companies. She consults with healthcare, biotech, corporate, and financial institutions.

A graduate of the Australian Institute of Company Directors (GAICD), Linda is a non-executive director on several Healthcare boards within Australia and abroad. Among her roles, Dr. Friedland is Deputy Chairman of the Neurological Council of Western Australia (NCWA), senior consultant to TargImmune Therapeutics (Basel, Switzerland), co-founder and director of FFD Capital LLC (USA) and Asia- Pacific partner for Camelot BioCapital. An author of seven healthcare-related bestsellers with a long career in television and health media, she has developed public health and disease management programs in Asia, USA, Australia, Africa, and the UK and delivered keynote addresses in more than 30 countries.

In accordance with the Company's Constitution, Dr Linda Friedland will stand for election at the Company's Annual General Meeting in November 2023.